
Precision biologics: the key to reducing antibiotic use in livestock?
Canada’s NovoBind, which is developing a precision biologics platform to protect livestock against pathogenic bacteria, viruses, and parasites, has closed a Series A round of funding.
Smoke & mirrors, not worth the extra cost: 50 US farmers speak out on carbon markets